Citigroup’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$617K Buy
65,568
+5,168
+9% +$48.6K ﹤0.01% 2808
2025
Q1
$327K Sell
60,400
-5,251
-8% -$28.5K ﹤0.01% 3153
2024
Q4
$489K Buy
65,651
+19,142
+41% +$143K ﹤0.01% 3038
2024
Q3
$372K Buy
46,509
+25,863
+125% +$207K ﹤0.01% 3177
2024
Q2
$180K Sell
20,646
-69,316
-77% -$603K ﹤0.01% 3226
2024
Q1
$1.86M Buy
89,962
+85,290
+1,826% +$1.76M ﹤0.01% 1881
2023
Q4
$108K Buy
4,672
+4,660
+38,833% +$108K ﹤0.01% 3435
2023
Q3
$96 Sell
12
-7,787
-100% -$62.3K ﹤0.01% 4649
2023
Q2
$67.9K Buy
+7,799
New +$67.9K ﹤0.01% 3787
2023
Q1
Sell
-176
Closed -$616 4800
2022
Q4
$616 Sell
176
-604
-77% -$2.11K ﹤0.01% 4685
2022
Q3
$6K Sell
780
-1,733
-69% -$13.3K ﹤0.01% 4400
2022
Q2
$20K Buy
2,513
+605
+32% +$4.82K ﹤0.01% 4301
2022
Q1
$24K Sell
1,908
-4,467
-70% -$56.2K ﹤0.01% 4321
2021
Q4
$78K Buy
6,375
+3,965
+165% +$48.5K ﹤0.01% 4083
2021
Q3
$25K Buy
2,410
+1,404
+140% +$14.6K ﹤0.01% 4373
2021
Q2
$9K Sell
1,006
-783
-44% -$7.01K ﹤0.01% 5014
2021
Q1
$18K Buy
+1,789
New +$18K ﹤0.01% 4644
2020
Q4
Sell
-737
Closed -$4K 5214
2020
Q3
$4K Sell
737
-23
-3% -$125 ﹤0.01% 4743
2020
Q2
$6K Sell
760
-1,650
-68% -$13K ﹤0.01% 4768
2020
Q1
$25K Buy
2,410
+307
+15% +$3.19K ﹤0.01% 4237
2019
Q4
$33K Buy
2,103
+1,569
+294% +$24.6K ﹤0.01% 4235
2019
Q3
$10K Sell
534
-1,394
-72% -$26.1K ﹤0.01% 4558
2019
Q2
$32K Sell
1,928
-6,177
-76% -$103K ﹤0.01% 4362
2019
Q1
$146K Buy
+8,105
New +$146K ﹤0.01% 3330
2015
Q1
Sell
-41
Closed -$2K 5514
2014
Q4
$2K Sell
41
-3
-7% -$146 ﹤0.01% 5212
2014
Q3
$2K Buy
+44
New +$2K ﹤0.01% 5144
2014
Q2
Sell
-8
Closed 5512
2014
Q1
$0 Buy
+8
New ﹤0.01% 5478
2013
Q4
Sell
-30
Closed -$1K 5383
2013
Q3
$1K Buy
+30
New +$1K ﹤0.01% 5014